ArticleBMC cancer2026
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated With Metastatic Cervical Cancer Tissue.Cancer genomics & proteomicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo construct and validate a predictive model to better differentiate the survival outcomes for locally advanced cervical cancer patients (LACC) receiving concurrent chemoradiotherapy (CCRT).
methodsPatients were separately classified as vaginal invasion (VI), parametrial invasion (PI) or lymph node metastasis (LNM) based on disease extension. The survival outcomes were compared. Cox regression were performed to identify risk factors. Accordingly, the nomogram was constructed and validated. Moreover, the predictive performance between model and 2018 FIGO staging system was compared.
resultsLNM could significantly impair the survival for patients with VI (5-yr OS:77.7% VS 95.6%) (P = 0.018). Patients with bilateral extension to pelvic sidewall (BEP) and bilateral parametrial invasion (BPI) showed worse 5-yr OS (42.4% and 60.9%) compared to those with unilateral extension to pelvic sidewall (UEP) and unilateral parametrial invasion (UPI) (81.7% and 89.1%) (P < 0.001). Additionally, LNM didn’t affect the prognosis of patients with PI. The nomogram incorporating pathology, PI and pelvic LNM was constructed and showed decent predictive performance both in the training and test cohort. Besides, nomogram possessed better predictive ability than 2018 FIGO staging system both in the training (5-yr AUC: 0.79 VS 0.59) and validation cohort (5-yr AUC: 0.77 VS 0.64).
conclusionsLNM would impair the survival for patients with VI not those with PI and a nomogram was constructed and validated to better differentiate the prognosis for LACC patients than FIGO staging system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.